Neuromyelitis Optica Spectrum Disorder
1 competing product in clinical development for Neuromyelitis Optica Spectrum Disorder.
Pipeline by Phase
Approved1
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Satralizumab 120 mg | Chugai Pharmaceutical | Approved | Terminated | 35 |